Bixiye
P75-22 Update to 2023 Renewal Changes Summaries for BP PCC & Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022
Natiijooyinka Raadinta
Soo bandhiga 1131 - 1140 ee natiijooyinka 4162
Bixiye
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
QP112R1-20 Changes to Electronic Funds Transfer Processes
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023